Office of Disease Prevention
Active
- Assistance listing
- 93.681
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Treasury account
-
- 75-0846-0-1-552
- More information
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institutes of Health Office of Disease Prevention administers a portfolio of Research Project Grants and Cooperative Agreements (CFDA 93.681) to support discrete disease prevention research projects conducted by named investigators at institutions nationwide, with application deadlines and funding availability determined by individual Notices of Funding Opportunity.
The program funds hypothesis-driven disease prevention research across a broad range of activity codes, including the most commonly deployed R01 (Research Project Grant), as well as early-stage exploratory grants (R03, R21), career development awards (R00, R37), center grants (P01, P42, U01, U19), and cooperative agreement mechanisms (UC, UM, UH, and DP series). Research Project Grants represent the dominant assistance type within the portfolio, with Cooperative Agreements comprising a secondary share. The program accepts renewal applications as described in individual Notices of Funding Opportunity, and all competitive applications undergo scientific and technical merit review by an appropriate scientific peer review panel and the relevant NIH Institute or Center Advisory Council.
The source provided does not include a recent grant award portfolio block, preventing analysis of award volume, funding concentration by component NIH institute or center, or representative recent award magnitudes and recipients. The source does not identify currently open grant opportunities or recent opportunity posting dates. Applicants should consult individual Notices of Funding Opportunity for program-specific deadlines, eligibility requirements, and available funding amounts. The source confirms that all financial records must be retained for three years from submission of the final expenditure report, and that applicants are subject to 2 CFR Subpart F audit requirements. Applicants may appeal substantive or procedural aspects of peer review through NIH's formal appeal process as documented on the NIH Center for Scientific Review website.
Objective and description
- Objective
The Office of Disease Prevention (ODP) is the lead office at the National Institutes of Health (NIH) responsible for assessing, facilitating, and stimulating research in disease prevention, and disseminating the results of this research to improve pu
- Description
Research Project Grants are awards made to an institution/organization to support discrete, specified, circumscribed projects to be performed by named investigators in areas representing their specific interest and competencies. Research Project Grants and Cooperative Agreements may include the following activity codes: R00, R01, R03, R15, R16, R21, R33, R34, R35, R36, R37, R50, R56, R61, RC1, RC2, RC3, RC4, RF1, RL1, RL2, RL9, P01, P42, PM1, PN1, RM1, UA5, UC1, UC2, UC3, UC4, UC7, UF1, UG3, UH2, UH3, UH5, UM1, UM2, U01, U19, U34, U3R, DP1, DP2, DP3, DP4, DP5. NIH's most commonly used grant program is the Research Project Grant Program (R01).
Eligibility
- Applicant eligibility
Applicants should review the eligibility information in individual notices of funding opportunity.
- Uses of assistance
Health/Medical, Higher Education (includes Research) Grantee agrees to administer the grant in accordance with the regulations and policies governing the research grant programs of the Public Health Service as stated in the terms and conditions on the application for the grant.
- Use restrictions
Please note specific restrictions listed in individual notices of funding opportunity.
How to apply
- Award procedure
All applications for research grants, cooperative agreements, training, and SBIR and STTR grants are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by the Advisory Council of the NIH Institute or Center that will manage the award. All competitive applications compete for available funds on the basis of scientific and technical merit, program relevance, and program balance.
- Deadlines
Refer to Notices of Funding Opportunity for deadlines.
- Renewals
Renewal applications are accepted, as described in the relevant Notice of Funding Opportunity.
- Appeals
A principal investigator (P.I.) may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH web site at: http://public.csr.nih.gov/ApplicantResources/InitialReviewResultsAppeals/Pages/
Quick answers
What is Assistance Listing 93.681?
Assistance Listing 93.681 is Office of Disease Prevention, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Office of Disease Prevention?
Its CFDA number is 93.681: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program